Parnassus Value Equity Fund Q3 2026 Portfolio Review

Impact · against what's priced in

The Parnassus portfolio review provides no material catalyst for the listed stocks, as attributing a stock's contribution to a fund's quarterly performance does not provide new fundamental data. While TMO and CME were positive contributors, this is a retrospective observation of price action rather than a change in the underlying drivers the market is pricing.

CME+0.00

Doesn't touch the price's assumptions

In context

Being a top contributor to the Parnassus fund is a lagging indicator of price movement and does not offer evidence that prediction markets or 24/7 futures are scaling as the market currently declines to pay for.